Free Trial

Standard BioTools (LAB) Earnings Date, Estimates & Call Transcripts

Standard BioTools logo
$0.98 +0.04 (+4.71%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$0.99 +0.01 (+0.72%)
As of 08:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Standard BioTools Earnings Summary

Standard BioTools announced Q4 2025 earnings on February 24, 2026, reporting an EPS of $0.05, which topped analysts' consensus estimates of -$0.03 by $0.08. Quarterly revenue was reported to be $23.80 million, above the consensus estimate of $18.50 million. With a trailing EPS of -$0.20,

Latest Q4
Earnings Date
Feb. 24Estimated
Consensus EPS
(Feb. 24)
-$0.03
Actual EPS
(Feb. 24)
$0.05 Beat By $0.08
Actual Revenue
(Feb. 24)
$23.80M

Q4 2025 Earnings Resources

Get Standard BioTools Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Standard BioTools and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Standard BioTools Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.10) EPS

Standard BioTools Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/24/2026Q4 2025-$0.03$0.05+$0.08$0.05$18.50M$23.80M
7/31/2024Q2 2024-$0.10-$0.09+$0.01-$0.06$48.15M$37.21M
5/8/2024Q1 2024-$0.13-$0.26 -$0.13-$0.25$46.50M$45.54M

Data powered by Fiscal.ai.


This page (NASDAQ:LAB) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners